Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of trans-signaling approach in chimeric antigen receptors

Use of trans-signaling approach in chimeric antigen receptors

US Patent 11484552 · Granted Nov 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Fully-human T-cell receptor specific for the 369-377 epitope derived from the He2025
Treatment of a canine CD20 positive disease or condition using a canine CD20-spe2025
Switch costimulatory receptors2025
Compositions and methods for generating a persisting population of T cells usefu2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Altering gene expression in cart cells and uses thereof2025
Use of trans-signaling approach in chimeric antigen receptors2025
Use of trans-signaling approach in chimeric antigen receptors2025
Methods for improving the efficacy and expansion of immune cells2025
Methods for improving the efficacy and expansion of immune cells2025
Use of the CD2 signaling domain in second-generation chimeric antigen receptors2025